Full bill text
The complete text as filed. This is the legislature's own wording — not a summary.
As Reported by the House Health Committee 136th General Assembly Regular Session Sub. H. B. No. 324 2025-2026 Representatives Mathews, A., Craig Cosponsors: Representatives Schmidt, Gross, King, Miller, M., Stewart To enact section 3715.39 of the Revised Code to 1 establish conditions on the prescribing of 2 prescription drugs causing severe adverse 3 effects and to name this act the Patient 4 Protection Act. 5 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF OHIO: Section 1. That section 3715.39 of the Revised Code be 6 enacted to read as follows: 7 Sec. 3715.39. (A) As used in this section : 8 (1) "Dangerous drug" and "prescriber" have the same 9 meanings as in section 4729.01 of the Revised Code, except that 10 a prescriber does not include a veterinarian licensed under 11 Chapter 4741. of the Revised Code. 12 (2) "Severe adverse effect" means any of the following: 13 (a) Death; 14 (b) Infection requiring hospitalization; 15 (c) Hemorrhaging requiring hospitalization; 16 (d) Organ failure; 17
Sub. H. B. No. 324 Page 2 As Reported by the House Health Committee (e) Sepsis. 18 (B) Before a prescriber may issue for a patient a 19 prescription for a dangerous drug that causes one or more severe 20 adverse effects in greater than five per cent of the drug's 21 users, the prescriber shall do all of the following: 22 (1) Conduct an in-person examination of the patient; 23 (2) Inform the patient that the drug causes one or more 24 severe adverse effects in greater than five per cent of the 25 drug's users; 26 (3) Schedule the patient for a follow-up appointment. 27 (C)(1) For purposes of this section, the director of 28 health is responsible for determining if a dangerous drug causes 29 one or more severe adverse effects in greater than five per cent 30 of the drug's users. In making such a determination, both of the 31 following apply: 32 (a) The director shall consult with the superintendent of 33 insurance and executive directors of the state board of pharmacy 34 and state medical board. 35 (b) The director shall base the determination on the 36 greater of insurance claims, patient reports of severe adverse 37 effects to health care professionals, and any applicable data 38 available from the United States food and drug administration. 39 (2) The director of health shall prepare and update as 40 needed a list containing each dangerous drug that the director 41 determines causes one or more severe adverse effects in greater 42 than five per cent of the drug's users. The director shall make 43 the list, and each of its updates, available to the public on 44 the internet web site maintained by the department of health. 45
Sub. H. B. No. 324 Page 3 As Reported by the House Health Committee Section 2. This act shall be known as the Patient 46 Protection Act. 47
Text is provided by LegiScan and may lag the latest filed version. Compare with the official version ↗